Equities research analysts at Wedbush upped their Q1 2025 earnings per share estimates for Beam Therapeutics in a research note issued on Monday, March 10th. Wedbush analyst D. Nierengarten now ...

Stacey Winter joined Wedbush Securities in 2002 and currently serves as managing director, head of equity sales and head of ...

Wedbush said Friday it expects North American box office to rise at least 7% in 2025, with double-digit growth from the ...

US equity indexes rose after midday trading on Friday amid a reduced risk of a government shutdown and President Donald Trump's "productive" discussions with Russian President Vladimir Putin on the ...

Wedbush raised the firm’s price target on Turtle Beach (TBCH) to $21 from $20 and keeps an Outperform rating on the shares. The firm notes that ...

Wedbush analyst Richard Anderson maintained a Sell rating on CareTrust REIT (CTRE – Research Report) today and set a price target of $26.00.

Investors have an opportunity to buy and hold quality growth stocks amid the ongoing selloff in 2025. Today, fundamentally ...

New York (CNN) — US stocks slid Thursday and the S&P 500 closed in correction, down more than 10% from its record high in ...